FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/03/2023
Voltar para busca
Dado oficial do USPTO
CANCER GRAND CHALLENGES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
06/03/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
41, 42
Data de depósito
08/04/2021
Data de registro
25/10/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/10/2022
Última transação
25/10/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
24
Localização do titular
GB
Examinador
VALLILLO, MELISSA
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a black background and the wording "CANCER GRAND CHALLENGES" in white and a design comprising a circle with uneven wavy sides in gray.
Titulares e representantes
Titulares
C. U. (pessoa física)
Representantes
David J. Hrina Brennan, Manna & Diamond, LLC
Classificação técnica
Classes Nice
Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 41
Educational servicesarranging for students to participate in PhD training programmes and lab exchanges relating to cancer and treatments thereof; educational servicesseminars and conferences relating to cancer and treatments thereof provided via a website or via social mediadissemination of educational material relating to cancer and treatments thereof; dissemination of educational material relating to cancer and treatments thereof provided via a website or via social media; organisation of sporting and cultural activities for charitable purposes; arranging and conducting of conferencesworkshopscoursesseminars and educational eventssymposiums in the field of cancer research; education servicesarranging for students to participate in PhD training programmes and lab exchanges in relation to alleviationdiagnosisprevention and treatment of cancer; education services namely arranging for students to participate in PhD training programmes and lab exchanges in relation to alleviationdiagnosisprevention and treatment of cancer provided via a website or via social media; publication of booksnewspapersnewslettersmagazines relating to cancer and treatments thereofvideo production services in the fields of cancer and treatments thereof; providing online non-downloadable videos featuring scientific information in the field of cancer and treatments thereof; production of videos relating to alleviationdiagnosisprevention and treatment of cancer; provision of audio and visual mediaonline non-downloadable videos via communications networks to cancer and treatments thereofdeveloping and conducting educational programs in the fields of healthdietnutritioncancer and cancer prevention; provision of recreation facilities; organisation of quizzes in the nature of educational tests in the fields of cancer and cancer prevention; arranging for students to participate in educational activitiestraining in the field of cancer prevention; organising events being the provision of entertainment activitiesconducting social entertainment events and conducting sporting and cultural activities for charitable purposesarranging and conducting of educational eventsseminars and conferences in the field of cancer researchtreatment and prevention for charitable purposes
Classe 42
Scientific laboratory analysis; scientific laboratory research; scientific laboratory services; medical laboratory testing services; medical laboratory services; medical and scientific research services in relation to the causessymptomsdiagnosistreatment and prevention of cancer; genetic research; provision of scientific research facilities; scientific research laboratories; scientific research in relation to medicines and pharmaceuticals; medical research services
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
13/02/2023
FIMP
FINAL DISPOSITION PROCESSED
13/02/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/01/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/10/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
25/10/2022
GPNX
NOTIFICATION PROCESSED BY IB
09/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/08/2022
PUBO
PUBLISHED FOR OPPOSITION
09/08/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/07/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
20/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/07/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/07/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/06/2022
GNFR
FINAL REFUSAL E-MAILED
08/06/2022
CNFR
FINAL REFUSAL WRITTEN
08/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/04/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/04/2022
RFNT
REFUSAL PROCESSED BY IB
23/01/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/01/2022
RFRR
REFUSAL PROCESSED BY MPU
05/01/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/12/2021
CNRT
NON-FINAL ACTION WRITTEN
06/12/2021
DOCK
ASSIGNED TO EXAMINER
29/11/2021
MAFR
APPLICATION FILING RECEIPT MAILED
10/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/08/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CANCER GRAND CHALLENGES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.